BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3369674)

  • 1. [Clinical study to evaluate the efficacy and acceptability of long-acting theophylline in children with asthma].
    Nelly RC
    Rev Alerg Mex (1987); 1988; 35(1):17-21. PubMed ID: 3369674
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
    Cantani A; Businco E; Businco L; Solano A; Calabretta C
    Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anhydrous theophylline in micropellets with prolonged action in asthmatic children].
    Massey LF; Escobedo V
    Rev Alerg Mex (1987); 1989; 36(6):245-51. PubMed ID: 2699068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy of theopek in bronchial asthma and chronic bronchitis].
    Korzh OB
    Ter Arkh; 1990; 62(3):82-4. PubMed ID: 2368005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prolonged-action theophylline in the treatment of bronchial asthma].
    Ter Arkh; 1989; 61(8):30-7. PubMed ID: 2588163
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effects of theophylline in the therapy of intractable asthmatic children. I. Clinical effects of a new sustained-release preparation of theophylline E-0686].
    Segawa H; Uematsu F; Iikura Y
    Arerugi; 1987 Jan; 36(1):38-48. PubMed ID: 3592990
    [No Abstract]   [Full Text] [Related]  

  • 7. [The clinical effect of sustained-release theophylline (Theo-Dur) for asthmatic children and serum theophylline level (author's transl)].
    Masaki T; Sekine H; Nagakura T; Iikura Y; Tomita Y; Asano T; Kajita T; Seo K
    Arerugi; 1981 Apr; 30(4):190-6. PubMed ID: 7337549
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monitoring of three delayed-release preparations of theophylline in the plasma of children: pharmacokinetic parameters and therapeutic significance].
    Domínguez Granados R; Pita Calandre E; Girón Caro F; Gómez Rubio M; Molina Font JA
    An Esp Pediatr; 1987 Nov; 27(5):357-61. PubMed ID: 3439657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary results of a new delayed-action theophylline preparation (1 dose in 24 hours) in the treatment of childhood asthma].
    Ciofetta G; Indinnimeo L; De Castro G; Lo Tesoriere A; Barretta MA; Lalia F; Zicari AM; Ronchetti R
    Minerva Pediatr; 1986 Oct; 38(19):843-8. PubMed ID: 3796546
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum pyridoxal concentration in children during theophylline therapy for bronchial asthma].
    Tanaka I; Hiraga Y; Inaba J; Fujino M; Kobayashi K
    Arerugi; 1994 Sep; 43(9):1172-8. PubMed ID: 7802601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
    Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
    Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms and peak expiratory flow rate: response to a slow release theophylline preparation.
    Ho TF; Ngiam TE; Koh PK
    Singapore Med J; 1983 Oct; 24(5):280-4. PubMed ID: 6669991
    [No Abstract]   [Full Text] [Related]  

  • 14. Compliance differences following administration of theophylline at six- and twelve-hour intervals.
    Tinkelman DG; Vanderpool GE; Carroll MS; Page EG; Spangler DL
    Ann Allergy; 1980 May; 44(5):283-6. PubMed ID: 7377640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum theophylline levels in children after a single dose of Uniphyllin Unicontin tablets.
    Nerminathan V; McKenzie SA
    Br J Clin Pract Suppl; 1984; 32():30-1. PubMed ID: 6432022
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sustained-release theophylline: study in a child population].
    Díaz Fernández M; Gracía Hidalgo A; Mateo Cañas G; López Elorze F
    An Esp Pediatr; 1986 Jan; 24(1):7-13. PubMed ID: 3963648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sustained-action oral theophylline in the asthmatic child. Clinical, pharmacokinetic and respiratory function studies].
    Baculard A; Morgant G; Gaultier C; Boule M; Tournier G
    Rev Fr Mal Respir; 1983; 11(6):833-46. PubMed ID: 6669796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical application of long-acting preparations of theophylline].
    Tanaka K
    Nihon Rinsho; 1996 Nov; 54(11):3108-12. PubMed ID: 8950963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma theophylline concentrations in asthmatic children receiving a twice daily theophylline preparation.
    Teo J; Lee HS; Teo PC
    Singapore Med J; 1986 Jun; 27(3):210-3. PubMed ID: 3764456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.